The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Omel'chenko A.Iu.

FGBU "Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina" Minzdrava Rossii

Soynov I.A.

Meshalkin Novosibirsk National Medical Research Center of Healthcare Ministry of Russia, Novosibirsk, Russia, Federal Center for Cardiovascular Surgery of Healthcare Ministry of Russia, Perm, Russia, Topchibashov Research Center for Surgery of Healthcare Ministry of Azerbaijan, Baku, Azerbaijan

Gorbatykh Iu.N.

Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina Minzdravsotsrazvitiia Rossii

Kulyabin Yu.Yu.

Meshalkin National Medical Research Center, Ministry of Health of the Russia, Novosibirsk, Russia

Gorbatykh A.V.

Meshalkin National Medical Research Center, Ministry of Health of the Russia, Novosibirsk, Russia

Nichay N.R.

Meshalkin National Medical Research Center, Ministry of Health of the Russia, Novosibirsk, Russia

Voitov A.V.

Meshalkin National Medical Research Center, Ministry of Health of the Russia, Novosibirsk, Russia

Bogochev-prokophiev A.V.

Siberian Biomedical Research Center Ministry of Health Russian Federation, Novosibirsk, Russia.

Right ventricular dysfunction after tetralogy of Fallot repair: are all questions resolved?

Authors:

Omel'chenko A.Iu., Soynov I.A., Gorbatykh Iu.N., Kulyabin Yu.Yu., Gorbatykh A.V., Nichay N.R., Voitov A.V., Bogochev-prokophiev A.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2017;(6): 84‑90

Read: 4105 times


To cite this article:

Omel'chenko AIu, Soynov IA, Gorbatykh IuN, et al. . Right ventricular dysfunction after tetralogy of Fallot repair: are all questions resolved? Pirogov Russian Journal of Surgery. 2017;(6):84‑90. (In Russ.)
https://doi.org/10.17116/hirurgia2017684-90

References:

  1. Sukhanov SG, Orekhova EN, Sinelnikov US i dr. Mechanical function of the right ventricle in infants with tetralogy of Fallot. Patologiya krovoobrascheniya i kardiohirurgiya. 2015;19:3:19-25. (In Russ.). doi:10.21688/1681-3472-2015-3
  2. Omelchenko AYu, Gorbatykh YuN, Soynov IA i dr. Assessment of right ventricular function after surgical repair of tetralogy of Fallot. Sibirskiy nauchnyiy meditsinskiy zhurnal. 2016;36:3:48-54. (In Russ.).
  3. Alghamdi MH, Mertens L, Lee W, et al. Longitudinal right ventricular function is a better predictor of right ventricular contribution to exercise performance than global or outflow tract ejection fraction in tetralogy of Fallot: a combined echocardiography and magnetic resonance study. Eur Heart J Cardiovasc Imaging. 2013;14(3):235-223. doi:10.1093/ehjci/jes1
  4. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31(23):2915-2957. doi:10.1093/eurheartj/ehq249
  5. Bigdelian H, Mardani D, Sedighi M. The effect of pulmonary valve replacement (pvr) surgery on hemodynamics of patients who underwent repair of tetralogy of fallot (TOF). J Cardiovasc Thorac Res. 2015;7(3):122-121. doi:10.15171/jcvtr.2015.26
  6. Bove T, Vandekerckhove K, Devos D, et al. Functional analysis of the anatomical right ventricular components: should assessment of right ventricular function after repair of tetralogy of Fallot be refined? Eur J Cardiothorac Surg. 2014;45(2):6-12. doi:10.1093/ejcts/ezt505
  7. Kim YY, Ruckdeschel E. Approach to residual pulmonary valve dysfunction in adults with repaired tetralogy of Fallot. Heart. 2016;102:1520-1526. doi:10.1136/heartjnl-2015-309067
  8. Sarris GE, Comas JV, Tobota Z, et al. Results of reparative surgery for tetralogy of Fallot: data from the European Association for Cardio-Thoracic Surgery Congenital Database. Eur J Cardiothorac Surg. 2012;42(5):766-774. doi:10.1093/ejcts/ezs478
  9. Jacobs JP, Mayer JE, Mavroudis C, et al. The society of thoracic surgeons congenital heart surgery database: 2016 update on outcomes and quality. Ann Thorac Surg. 2016;101:850-862. doi:10.1016/j.athoracsur.2016.01.057
  10. Loomba RS, Buelow MW, Woods RK. Complete repair of tetralogy of Fallot in the neonatal versus non-neonatal period: a meta-analysis. Pediatr Cardiol. 2017. doi:10.1007/s00246-017-1579-8
  11. Bové T, François K, Van De Kerckhove K, et al. Assessment of a right-ventricular infundibulum-sparing approach in transatrial-transpulmonary repair of tetralogy of Fallot. Eur J Cardiothorac Surg. 2012;41(1):126-133. doi:10.1016/j.ejcts.2011.03.050
  12. Morales DL, Zafar F, Heinle JS, et al. Right ventricular infundibulum sparing (RVIS) tetralogy of fallot repair: a review of over 300 patients. Ann Surg. 2009;250(4):611-617. doi:10.1097/SLA.0b013e3181b79958
  13. Omelchenko AYu, Gorbatykh YuN, Voitov AV, et al. Assessment of main hemodynamic parameters by transpulmonary thermodilution in children after complete repair of tetralogy of Fallot. Sibirskiy meditsinskiy zhurnal. 2016;31:3:55-60. (In Russ.).
  14. Morales DL, Zafar F, Fraser CD. Tetralogy of Fallot repair: the right ventricle infundibulum sparing (RVIS) strategy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009;54-58. doi:10.1053/j.pcsu.2009.02.001
  15. Omelchenko AYu, Gorbatykh YuN, Soynov IA i dr. Hemodynamic parameters and right ventricular function after radical correction of Fallot's tetrad. Permskiy meditsinskiy zhurnal. 2016;33:3:6-17. (In Russ.).
  16. Omelchenko AYu, Gorbatykh YuN, Soynov IA i dr. Hemodynamic and functioanl evaluation of the right ventricle after radical correction of Fallot''s tetrad. Meditsinskiy almanah. 2016;4(44):93-99. (In Russ.). doi:10.21145/2499-9954-2016-4-93-99
  17. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975-981. doi:10.1016/S0140-6736(00)02714-8
  18. Valente AM, Gauvreau K, Assenza GE, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014;100:247-253. doi:10.1136/heartjnl-2013-304958
  19. Gregg D, Foster E. Pulmonary insufficiency is the nexus of late complications in tetralogy of Fallot. Curr Cardiol Rep. 2007;9:315-322. doi:10.1007/BF02938380
  20. Therrien J, Siu SC, McLaughlin PR, et al. Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: are we operating too late? J Am Coll Cardiol. 2000;36:1670-1675. doi:10.1016/S0735-1097(00)00930-X
  21. Ferraz Cavalcanti PE, Sá MP, Santos CA, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol. 2013;62:2227-2243. doi:10.1016/j.jacc.2013.04.107
  22. Geva T, Gauvreau K, Powell AJ, et al. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation. 2010;122:201-208. doi:10.1161/CIRCULATIONAHA.110.951178
  23. Therrien J, Provost Y, Merchant N, et al. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779-782. doi:10.1016/j.amjcard.2004.11.037
  24. Geva T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006;9:11—22. doi:10.1053/j.pcsu.2006.02.009
  25. Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007;116:545-551. doi:10.1161/CIRCULATIONAHA.106.659664
  26. Bokma JP, Winter MM, Oosterhof T, et al. Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Eur Heart J. 2016;37:829-835. doi:10.1093/eurheartj/ehv550
  27. Buechel ER, Dave HH, Kellenberger CJ, et al. Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance. Eur Heart J. 2005;26:2721-2727. doi:10.1093/eurheartj/ehi581
  28. Frigiola A, Tsang V, Bull C, et al. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome? Circulation. 2008;118:182-190. doi:10.1161/CIRCULATIONAHA.107.756825
  29. Lee C, Kim YM, Lee CH, et al. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol. 2012;60:1005-1014. doi:10.1016/j.jacc.2012.03.077
  30. Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot: the quest continues. Circulation. 2013;128:1855-1857. doi:10.1161/CIRCULATIONAHA.113.005878
  31. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008;118:714-833. doi:doi:10.1161/CIRCULATIONAHA.108.190811
  32. Chaturvedi RR, Kilner PJ, White PA, et al. Increased airway pressure and simulated branch pulmonary artery stenosis increase pulmonary regurgitation after repair of tetralogy of Fallot. Real-time analysis with a conductance catheter technique. Circulation. 1997;95:643-649. doi:doi:10.1161/01.CIR.95.3.643
  33. Silversides CK, Kiess M, Beauchesne L, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can J Cardiol. 2010;26:80-97.
  34. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC guidelines for the management of grown-up congenital heart disease. Eur Heart J. 2010;31:2915-2957. doi:10.1093/eurheartj/ehq249
  35. Gorbatyh YuN, Sinelnikov YS, Naberuhin YuL, i dr. Patient selection for right-sided conduit replacement: pre-op examination, indications for re-interventions. Patologiya krovoobrascheniya i kardiohirurgiya. 2011;3:13-16. (In Russ.).
  36. Vitanova K, Cleuziou J, Hörer J, et al. Which type of conduit to choose for right ventricular outflow tract reconstruction in patients below 1 year of age? Eur J Cardiothorac Surg. 2014;46(6):961-966. doi:10.1093/ejcts/ezu080
  37. Sfyridis PG, Avramidis DP, Kirvassilis GV, et al. The contegra valved heterograft conduit for right ventricular outflow tract reconstruction: a reliable solution. Hellenic J Cardiol. 2011;52:501-508.
  38. Breymann T, Blanz U, Wojtalik MA, et al. European Contegra multicentre study: 7-year results after 165 valved bovine jugular vein graft implantations. Thorac Cardiovasc Surg. 2009;57:257-269. doi:10.1055/s-0029-1185513
  39. Zhuravleva IYu, Nichai NR, Dokuchaeva AA, i dr. Clinical morphological analysis of Contegra dysfunction in infants. Patologiya krovoobrascheniya i kardiohirurgiya. 2016;20:1:56-61. (In Russ.). doi:10.21688/1681-3472-2016-1-56-61
  40. Brown JW, Ruzmetov M, Rodefeld MD, et al. Valved bovine jugular vein conduits for right ventricular outflow tract reconstruction in children: an attractive alternative to pulmonary homograft. Ann Thorac Surg. 2006;82:909-916. doi:10.1016/j.athoracsur.2006.03.008
  41. Meyns B, Van Garsse L, Boshoff D, et al. The Contegra conduit in the right ventricular outflow tract induces supravalvar stenosis. J Thorac Cardiovasc Surg. 2004;128:834-840. doi:10.1016/j.jtcvs.2004.08.015
  42. Gober V, Berdat P, Pavlovic M, at. al. Adverse mid-term outcome following RVOT reconstruction using the Contegra valved bovine jugular vein. Ann Thorac Surg. 2005;79:625-631. doi:10.1016/j.athoracsur.2004.07.085
  43. Shi-MinYuan. The Contegra Valved Bovine Conduit: A Biomaterial for the Surgical Treatment of Congenital Heart Defects. Arq Bras Cardiol. 2012;99:6:1159-1165.
  44. Yong MS, Yim D, d’Udekem Y, at at. Medium-term outcomes of bovine jugular vein graft and homograft conduits in children. ANZ J Surg. 2015;85:381-385. doi:10.1111/ans.13018
  45. Urso S, Rega F, Meuris B, et al. The Contegra conduit in the right ventricular outflow tract is an independent risk factor for graft replacement. Eur J Cardio-thorac Surg. 2011;40:603-609. doi:10.1016/j.ejcts.2010.11.081
  46. Corno AF. Valved Conduits right ventricle to pulmonary artery for complex congenital heart defects. Current Concepts in General Thoracic Surgery. 2012;45:101-112.
  47. Belli E, Salihoglu E, Leobon B, et al. The performance of Hancock porcine-valved Dacron conduit for right ventricular outflow tract reconstruction. Ann Thorac Surg. 2010;89:152-157. doi:10.1016/j.athoracsur.2009.09.046
  48. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403-1405. doi:10.1016/S0140-6736(00)02844-0
  49. Virk SA, Liou K, Chandrakumar D, et al. Percutaneous pulmonary valve implantation: a systematic review of clinical outcomes. Int J Cardiol. 2015;201:487-489. doi:10.1016/j.ijcard.2015.08.119
  50. McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010;122:507-516. doi:10.1161/CIRCULATIONAHA.109.921692
  51. Fraisse A, Aldebert P, Malekzadeh-Milani S, et al. Melody transcatheter pulmonary valve implantation: results from a French registry. Arch Cardiovasc Dis. 2014;107:607-614. doi:10.1016/j.acvd.2014.10.001
  52. Buber J, Bergersen L, Lock JE, et al. Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv. 2013;6:301-310. doi:10.1161/CIRCINTERVENTIONS.112.000348
  53. Van Dijck I, Budts W, Cools B, et al. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart. 2015;101:788-793. doi:10.1136/heartjnl-2014-306761
  54. Patel M, Malekzadeh-Milani S, Ladouceur M, et al. Percutaneous pulmonary valve endocarditis: incidence, prevention and management. Arch Cardiovasc Dis. 2014;107:615-624. doi:10.1016/j.acvd.2014.07.052
  55. Borik S, Crean A, Horlick E, et al. Percutaneous pulmonary valve implantation: 5 years of follow-up: does age influence outcomes? Circ Cardiovasc Interv. 2015;8:001745. doi:10.1161/CIRCINTERVENTIONS.114.001745

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.